N

Nexstim Oyj
OMXH:NXTMH

Watchlist Manager
Nexstim Oyj
OMXH:NXTMH
Watchlist
Price: 14.1 EUR Market Closed
Market Cap: 101.7m EUR

Profitability Summary

Nexstim Oyj's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Nexstim Oyj

Revenue
10.1m EUR
Cost of Revenue
-567.8k EUR
Gross Profit
9.5m EUR
Operating Expenses
-9.4m EUR
Operating Income
82.4k EUR
Other Expenses
-365.4k EUR
Net Income
-283k EUR

Margins Comparison
Nexstim Oyj Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FI
Nexstim Oyj
OMXH:NXTMH
101.3m EUR
94%
1%
-3%
US
Abbott Laboratories
NYSE:ABT
223.4B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
200.6B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
136.7B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
135.8B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
126.4B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
49.8B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
57.1B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
48.4B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.5B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Nexstim Oyj Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FI
Nexstim Oyj
OMXH:NXTMH
101.3m EUR
-11%
-2%
1%
1%
US
Abbott Laboratories
NYSE:ABT
223.4B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
200.6B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
136.7B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
135.8B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
126.4B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
49.8B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
57.1B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
48.4B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.5B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less